IL34 and rheumatoid arthritis: Reestablishing the balance between Treg and Th17 cell populations in RA by inhibiting NLRP3 inflammasome has exhibited promising results, which alludes to a potential therapeutic role of IL-34 for rebalancing Treg and Th17 cell populations (89).